# 21 CFR 556.75 Bambermycins.

21 CFR 556.75 Bambermycins., “Bambermycins”, is a CFR section of [21 CFR Part 556, Subpart B—Specific Tolerances for Residues of Approved and Conditionally Approved New Animal Drugs](https://ontology.bommaritollc.com/id/01a0f094-b653-70b3-90b9-7d00ac09f2f1); in force.

IRI: <https://ontology.bommaritollc.com/id/01a0f094-c914-7262-8d06-e98862ee53d4>

Within: [Title 21—Food and Drugs](https://ontology.bommaritollc.com/id/01a0f094-b437-7426-9a1d-f0a9f3d3e1aa) › [21 CFR Chapter I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES](https://ontology.bommaritollc.com/id/01a0f094-b455-74b7-9458-ed95d7b5ea58) › [21 CFR Chapter I, Subchapter E—ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS](https://ontology.bommaritollc.com/id/01a0f094-b631-77c0-8360-43217423fdac) › [21 CFR Part 556—Tolerances for residues of new animal drugs in food](https://ontology.bommaritollc.com/id/01a0f094-b878-749e-b802-68f33d384ce3) › [21 CFR Part 556, Subpart B—Specific Tolerances for Residues of Approved and Conditionally Approved New Animal Drugs](https://ontology.bommaritollc.com/id/01a0f094-b653-70b3-90b9-7d00ac09f2f1)

Type: [schema:Legislation](https://schema.org/Legislation)

- `adms:identifier`: [cfr-section 21 CFR 556.75](https://ontology.bommaritollc.com/id/01a0f094-c914-7262-8d06-e994a685456d)
- `eli:cites`: [21 CFR 558.95 Bambermycins.](https://ontology.bommaritollc.com/id/01a0f094-c9af-70bf-ab95-35e2ecac7dde)
- `prov:wasDerivedFrom`:
  - [evidence from https://www.govinfo.gov/app/details/CFR-2025-title21-vol1](https://ontology.bommaritollc.com/id/01a0f094-c914-7262-8d06-e9874a61eb12)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f094-e428-7088-8abb-f3fb6ec6df3f)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f0d0-c75f-73ed-bedb-ab146f66b5d4)
  - [evidence from https://www.govinfo.gov/link/cfr/21/556?sectionnum=75&year=mostrecent&link-type=details](https://ontology.bommaritollc.com/id/01a10f17-697b-73e5-b97c-7445b552724e)
- `schema:isPartOf`: [21 CFR Part 556, Subpart B—Specific Tolerances for Residues of Approved and Conditionally Approved New Animal Drugs](https://ontology.bommaritollc.com/id/01a0f094-b653-70b3-90b9-7d00ac09f2f1)
- `schema:legislationIdentifier`: 21 CFR 556.75
- `schema:legislationJurisdiction`: [United States](https://ontology.bommaritollc.com/id/01a0ed8e-f797-7004-b7f5-bec2695977c0)
- `schema:legislationLegalForce`: [schema:InForce](https://schema.org/InForce)
- `schema:legislationType`: [CFR section](https://ontology.bommaritollc.com/vocab/leg/cfrSection)
- `schema:name`: Bambermycins
- `schema:url`: [https://www.govinfo.gov/link/cfr/21/556?sectionnum=75&year=mostrecent&link-type=details](https://www.govinfo.gov/link/cfr/21/556?sectionnum=75&year=mostrecent&link-type=details)
- `skos:prefLabel`: 21 CFR 556.75 Bambermycins.

## Elsewhere

- [Official page](https://www.govinfo.gov/link/cfr/21/556?sectionnum=75&year=mostrecent&link-type=details) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/CFR-2025-title21-vol1) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/) (www.govinfo.gov)

## Pointing here

- Cited by (1; `eli:cites`):
  - [21 CFR 558.95 Bambermycins.](https://ontology.bommaritollc.com/id/01a0f094-c9af-70bf-ab95-35e2ecac7dde)

---
Also as: [Turtle](https://ontology.bommaritollc.com/id/01a0f094-c914-7262-8d06-e98862ee53d4.ttl), [JSON-LD](https://ontology.bommaritollc.com/id/01a0f094-c914-7262-8d06-e98862ee53d4.jsonld), [N-Triples](https://ontology.bommaritollc.com/id/01a0f094-c914-7262-8d06-e98862ee53d4.nt), [HTML](https://ontology.bommaritollc.com/id/01a0f094-c914-7262-8d06-e98862ee53d4)
Cite as: 21 CFR 556.75 Bambermycins.. bc-ontology, release 0.1.0-rc38, 2026-10-21. https://ontology.bommaritollc.com/id/01a0f094-c914-7262-8d06-e98862ee53d4
Release 0.1.0-rc38, graph hash 05350a11cf9d0c42fba51e92b877115781ab65cb92afcd6b172ff9f8f4abf0bd.
